Skip Over Navigation Links

NIGMS Support for New Investigators

In 1998, NIGMS established procedures and funding policies to ensure support for adequate numbers of new investigators defined as a research applicant who has not yet been awarded a substantial, competing NIH grant. Under these policies, an applicant's status as a New Investigator (NI) is one of the criteria used in funding decisions made by the Institute. In FY 2009, NIH announced a new policy involving the identification of Early Stage Investigators (ESIs). ESIs are New Investigators who are within 10 years of completing either their terminal research degree or their medical residency (whichever is later) at the time they apply for R01 grants.

NIGMS awarded grants to 203 New Investigators. Of these, 105 were ESIs.

Fiscal Years 2001-2011

New Investigators Funded by NIGMS on R01s

Graph showing number of new investigators funded by NIGMS on R01s in Fiscal Years 2001-2011

New Investigator Status Report 2011

(OER Data as FY2011 Actuals)

New (Type1) Applications and Awards

Institute All investigators were new investigators At least one investigator was previously funded by NIH
Applications Awards Approximate Success Rate Applications Awards Approximate Success Rate
NIGMS 973 171 18% 1,408 222 16%
NIH 9,446 1,445 15% 14,412 2,154 15%

Applicants (number of people)

Institute New investigators Early Stage Investigators
Applicants Awardees Applicants Awardees
NIGMS 1,118 203 469 105
NIH 10,259 1,787 4,516 961

Notes: The status of R01 and DP2 awardees is determined for the assigned fiscal year of the award. An individual PI is designated as a New investigator: If the investigator has never received a major NIH RPG competing grant award (based on definition that resides at

Or, if the reporting fiscal year is the same as the fiscal year of the first major RPG competing grant award.

Prepared by the NIGMS Office of Program Analysis and Evaluation (OPAE).

This page last reviewed on December 5, 2012